Bone and Soft Tissue Cancer Care at Wilmot
Bone and soft tissue cancers are relatively rare. They also raise special concerns for patients. While beating cancer is always the first priority, many patients are also worried that they may lose a limb as a result of their cancer.
For these reasons and many others, it is important to find a center with doctors who treat bone and soft tissue cancers frequently and almost exclusively.
The Wilmot Cancer Center offers the region’s only doctors who specialize in bone and soft tissue cancers. Our doctors have fellowship training in orthopaedic oncology—the treatment of bone and soft tissue cancers. They see more patients with orthopaedic cancers than any other center in Upstate New York.
Wilmot is also part of the University of Rochester Medical Center, the country’s #1 center for orthopaedic research. This helps ensure that our doctors have the most current knowledge about all types of orthopaedic conditions.
The only doctors in the region who specialize in bone and soft tissue cancers.
Complete team of specialists for every aspect of your care.
Advanced limb-sparing surgeries.
Multi-modality reconstructive surgery team to help preserve limb function.
Widest range of implants for reconstructive surgeries.
Pathologists who specialize in bone and soft tissue disease.
Specialized musculoskeletal radiology team for minimally invasive image-guided biopsies.
The most up-to-date chemotherapy treatments.
State-of-the-art radiation therapies, including Intensity Modulated Radiation Therapy (IMRT).
Part of the nation’s largest orthopaedic research center.
Research on bone and soft tissue cancer.
There are two main types of research that matter to patients with bone or soft tissue cancer: clinical trials and basic science research.
Clinical trials can give patients access to cutting edge treatments, long before they become widely available. The Wilmot Cancer Center offers the most clinical trials in the region for bone and soft tissue cancer. As a result, we are able to offer our patients the widest array of treatment options.
As part of the University of Rochester Medical Center—the nation’s leading orthopaedic research center—Wilmot is also involved in cutting edge basic science research that is helping to identify the treatments of tomorrow. For example, we are currently studying ways to keep cancer from spreading—from bone to other areas of the body, and from other parts of the body to bone.
Our involvement in clinical trials and basic science research helps to keep our doctors at the leading edge of care for orthopaedic cancers. It also gives our patients the opportunity to be a part of improving care for future patients.
Current Bone & Soft Tissue Cancer Research at Wilmot
Bone & Soft Tissue Clinical Trials at Wilmot